Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in COVID-19 Patients: Report of a Structured Multidisciplinary Consensus

Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in COVID-19 Patients: Report of a Structured Multidisciplinary Consensus

Introduction: Adjunctive therapy with polyclonal intravenous immunoglobins (IVIg) is currently used for preventing or managing infections and sepsis, especially in immunocompromised patients. The pathobiology of COVID-19 and the mechanisms of action of Ig led to the consideration of this adjunctive...

Full description

Bibliographic Details
Main Authors: Irene Coloretti, Giorgio Berlot, Stefano Busani, Francesco Giuseppe De Rosa, Abele Donati, Francesco Forfori, Giacomo Grasselli, Lucia Mirabella, Carlo Tascini, Pierluigi Viale, Massimo Girardis
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Journal of Clinical Medicine
Subjects:
respiratory failure
COVID-19
intravenous immunoglobulin therapy
Online Access:https://www.mdpi.com/2077-0383/10/16/3500

Internet

https://www.mdpi.com/2077-0383/10/16/3500

Similar Items